Cargando…

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

SIMPLE SUMMARY: Updated international guidelines suggest NGS as the preferred procedure for NSCLC patients’ evaluation for predictive biomarkers, but NGS facilities are not available everywhere. Alternative molecular techniques are rapidly evolving, each with different characteristics and performanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leone, Alvaro, Muscarella, Lucia Anna, Graziano, Paolo, Tornese, Andrea, Grillo, Lucia Rosalba, Di Lorenzo, Angela, Bronzini, Monica, Scarpino, Stefania, Sparaneo, Angelo, Rossi, Giulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818630/ https://www.ncbi.nlm.nih.gov/pubmed/36612287 http://dx.doi.org/10.3390/cancers15010292

Ejemplares similares

Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing
por: Nkosi, Dingani, et al.
Publicado: (2023)

Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers
por: Gilson, Pauline, et al.
Publicado: (2023)

GeneFuse: detection and visualization of target gene fusions from DNA sequencing data
por: Chen, Shifu, et al.
Publicado: (2018)

Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples
por: Offerman, Saskia, et al.
Publicado: (2021)

Contribution of the Idylla(TM) System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations
por: Petiteau, Constance, et al.
Publicado: (2021)

Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad
por: Sparaneo, Angelo, et al.
Publicado: (2016)

NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way Forward
por: Fabrizio, Federico Pio, et al.
Publicado: (2020)

Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction
por: Fabrizio, Federico Pio, et al.
Publicado: (2023)

Automated Workflow for Somatic and Germline Next Generation Sequencing Analysis in Routine Clinical Cancer Diagnostics
por: Muscarella, Lucia Anna, et al.
Publicado: (2019)

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available
por: Ercolani, Cristiana, et al.
Publicado: (2022)

A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene
por: Muscarella, Lucia Anna, et al.
Publicado: (2017)

Diagnostic performance of Idylla MSI test in colorectal cancer biopsies
por: Ukkola, Iiris, et al.
Publicado: (2023)

Epigenetic Scanning of KEAP1 CpG Sites Uncovers New Molecular-Driven Patterns in Lung Adeno and Squamous Cell Carcinomas
por: Fabrizio, Federico Pio, et al.
Publicado: (2020)

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer
por: Ukkola, Iiris, et al.
Publicado: (2021)

Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review
por: Caputo, Alessandro, et al.
Publicado: (2021)

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
por: Malapelle, Umberto, et al.
Publicado: (2023)

Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy
por: Fabrizio, Federico Pio, et al.
Publicado: (2018)

Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing
por: Fabrizio, Federico Pio, et al.
Publicado: (2019)

Assessing and Evaluating the Scope and Constraints of Idylla Molecular Assays by Using Different Source Materials in Routine Diagnostic Settings
por: Boppudi, Sanga Mitra, et al.
Publicado: (2022)

An improved workflow for accurate and robust healthcare environmental surveillance using metagenomics
por: Shen, Jiaxian, et al.
Publicado: (2022)

Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs
por: Fabrizio, F. P., et al.
Publicado: (2018)

Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2019)

Clinical workflow for MR-only simulation and planning in prostate
por: Tyagi, Neelam, et al.
Publicado: (2017)

Fully automated diagnosis of MERS-CoV infection in respiratory specimen on the IdyllaTM MDx Platform
por: Trost, N., et al.
Publicado: (2016)

Performance of Idylla(™) RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer
por: Makutani, Yusuke, et al.
Publicado: (2022)

Neuroendocrine-Related Circulating Transcripts in Small-Cell Lung Cancers: Detection Methods and Future Perspectives
por: Muscarella, Lucia Anna, et al.
Publicado: (2021)

Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers
por: Goudschaal, Karin, et al.
Publicado: (2021)

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
por: Holm, Matilda, et al.
Publicado: (2020)

Validation of an MRI-only planning workflow for definitive pelvic radiotherapy
por: O’Connor, Laura M., et al.
Publicado: (2022)

Robust and Easy-to-Use One-Pot Workflow for Label-Free Single-Cell Proteomics
por: Matzinger, Manuel, et al.
Publicado: (2023)

Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla(TM) System
por: Boustany, Youssra, et al.
Publicado: (2023)

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
por: Bisschop, Cornelis, et al.
Publicado: (2018)

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test
por: De Luca, Caterina, et al.
Publicado: (2017)

Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing
por: Nkosi, Dingani, et al.
Publicado: (2022)

Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing
por: Fabrizio, Federico Pio, et al.
Publicado: (2022)

Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane
por: Bayat Mokhtari, Reza, et al.
Publicado: (2019)

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
por: Vivancos, Ana, et al.
Publicado: (2019)

Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test
por: Durślewicz, Justyna, et al.
Publicado: (2020)

Mixed Pulmonary Adenocarcinoma and Atypical Carcinoid: A Report of Two Cases of a Non-codified Entity With Biological Profile
por: Parente, Paola, et al.
Publicado: (2021)

Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform
por: Banyi, Norbert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lmdasablp2bt760u3vue67hhrg